Live Earnings Conference Call: CRH will host a live Q1 2025 TU earnings call on May 6, 2025 at 8:00AM ET. Get details.

CRH (CRH) Financials

$98.21 -0.30 (-0.30%)

Closing price 05/5/2025 03:59 PM Eastern

Extended Trading

$94.35 -3.86 (-3.93%)

As of 05:21 AM Eastern

Compare

Annual Income Statements for CRH

This table shows CRH's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	685	1,280	2,240	2,889	-	1,304	2,630	3,862	3,178	3,492
Consolidated Net Income / (Loss)	792	1,336	2,305	2,889	1,738	1,165	2,686	3,889	3,072	3,521
Net Income / (Loss) Continuing Operations	700	1,251	2,010	1,526	-	1,009	2,507	2,699	3,072	3,521
Total Pre-Tax Income	1,000	1,704	2,024	1,993	-	1,454	3,102	3,461	4,014	4,714
Total Operating Income	1,267	2,007	2,315	2,446	-	2,026	3,327	3,809	4,186	4,925
Total Gross Profit	7,240	8,651	8,863	9,058	9,273	8,565	9,827	10,815	11,963	12,701
Total Revenue	23,259	26,078	26,011	27,424	-	25,888	29,206	32,723	34,949	35,572
Operating Revenue	23,259	26,078	26,011	27,424	-	25,888	29,206	32,723	34,949	35,572
Total Cost of Revenue	16,019	17,427	17,148	18,391	-	17,323	19,379	21,908	22,986	22,871
Operating Cost of Revenue	16,019	17,427	17,148	18,391	-	17,323	19,379	21,908	22,986	22,871
Total Operating Expenses	5,973	6,643	6,548	6,612	-	6,539	6,500	7,006	7,777	7,776
Selling, General & Admin Expense	-	-	-	-	-	-	6,538	7,056	7,486	7,852
Impairment Charge	-	-	-	-	-	-	0.00	0.00	357	161
Other Special Charges / (Income)	-	-	-	-	-	-	-38	-50	-66	-237
Total Other Income / (Expense), net	-375	-359	-356	-453	-	-589	-225	-348	-172	-211
Interest Expense	431	411	362	-	-	438	315	344	376	612
Interest & Investment Income	8.69	8.42	14	-	-	0.00	0.00	65	206	143
Other Income / (Expense), net	48	44	-8.41	-453	-	-151	90	-69	-2.00	258
Income Tax Expense	300	453	14	467	-	445	650	762	925	1,085
Other Gains / (Losses), net	-	-	-	-	-	-	55	0.00	-17	-108
Net Income / (Loss) Discontinued Operations	92	85	296	1,388	-	312	179	1,190	0.00	0.00
Net Income / (Loss) Attributable to Noncontrolling Interest	-	-	-	-	-	-	56	27	-106	29
Basic Earnings per Share	$0.89	$1.50	$2.72	-	-	$1.43	$3.35	$5.15	$4.36	$5.06
Weighted Average Basic Shares Outstanding	-	-	838.96M	843.39M	799.64M	795.14M	780.20M	758.30M	723.90M	683.30M
Diluted Earnings per Share	$0.89	$1.49	$2.71	-	-	$1.42	$3.32	$5.11	$4.33	$5.02
Weighted Average Diluted Shares Outstanding	-	-	838.96M	843.39M	799.64M	795.14M	786.80M	764.10M	729.20M	689.50M
Weighted Average Basic & Diluted Shares Outstanding	-	-	838.96M	843.39M	799.64M	795.14M	774.14M	752.14M	690.36M	676.48M
Cash Dividends to Common per Share	-	-	-	-	-	-	$1.21	$1.27	$1.33	$1.40

This table shows CRH's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	-28	1,199	1,306	701	116	1,297	1,376	703
Consolidated Net Income / (Loss)	-31	1,212	1,318	573	114	1,309	1,389	709
Net Income / (Loss) Continuing Operations	-31	1,212	1,318	573	114	1,309	1,389	709
Total Pre-Tax Income	-39	1,578	1,720	755	99	1,733	1,895	987
Total Operating Income	2.00	1,613	1,788	783	28	1,829	1,964	1,104
Total Gross Profit	1,619	3,630	3,763	2,951	1,807	3,675	4,059	3,160
Total Revenue	6,427	9,709	10,128	8,685	6,533	9,654	10,515	8,870
Operating Revenue	6,427	9,709	10,128	8,685	6,533	9,654	10,515	8,870
Total Cost of Revenue	4,808	6,079	6,365	5,734	4,726	5,979	6,456	5,710
Operating Cost of Revenue	4,808	6,079	6,365	5,734	4,726	5,979	6,456	5,710
Total Operating Expenses	1,617	2,017	1,975	2,168	1,779	1,846	2,095	2,056
Selling, General & Admin Expense	1,622	2,035	1,990	1,839	1,787	1,948	2,184	1,933
Other Special Charges / (Income)	-5.00	-18	-15	-28	-8.00	-102	-89	-38
Total Other Income / (Expense), net	-41	-35	-68	-28	71	-96	-69	-117
Interest Expense	81	73	131	91	133	155	164	160
Interest & Investment Income	40	36	62	68	43	36	33	31
Other Income / (Expense), net	0.00	2.00	1.00	-5.00	161	23	62	12
Income Tax Expense	-14	379	416	144	-19	430	531	143
Other Gains / (Losses), net	-6.00	13	14	-38	-4.00	6.00	25	-135
Net Income / (Loss) Attributable to Noncontrolling Interest	-3.00	13	12	-128	-2.00	12	13	6.00
Basic Earnings per Share	($0.05)	$1.63	$1.81	$0.97	$0.16	$1.89	$1.99	$1.02
Weighted Average Basic Shares Outstanding	742.90M	734.70M	718.20M	723.90M	687.80M	685.50M	681.60M	683.30M
Diluted Earnings per Share	($0.05)	$1.62	$1.80	$0.96	$0.16	$1.88	$1.97	$1.01
Weighted Average Diluted Shares Outstanding	742.90M	738.20M	722.10M	729.20M	693.40M	688.80M	685.50M	689.50M
Weighted Average Basic & Diluted Shares Outstanding	-	-	-	690.36M	686.68M	682.78M	679.34M	676.48M

This table details how cash moves in and out of CRH's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	-4,181	-4,133	-5,388	-5,946	1,552	3,466	-1,938	153	454	-2,631
Net Cash From Operating Activities	1,057	-1,510	-2,392	-3,885	3,881	4,116	3,979	3,800	5,017	4,989
Net Cash From Continuing Operating Activities	1,057	-1,510	-2,392	-3,885	2,580	4,116	3,979	3,800	5,017	4,989
Net Income / (Loss) Continuing Operations	0.00	0.00	0.00	0.00	2,181	1,165	2,686	3,889	3,072	3,521
Consolidated Net Income / (Loss)	-	-	-	-	2,181	1,165	2,686	3,889	3,072	3,521
Depreciation Expense	916	1,061	1,208	1,265	1,721	1,624	1,551	1,577	1,633	1,798
Non-Cash Adjustments To Reconcile Net Income	205	-2,511	-3,285	-4,539	-1,024	1,185	27	-1,242	547	-14
Changes in Operating Assets and Liabilities, net	-64	-60	-315	-611	-364	142	-285	-424	-235	-316
Net Cash From Investing Activities	-8,886	-1,054	-3,466	-5,400	217	-1,347	-2,513	-917	-2,391	-6,291
Net Cash From Continuing Investing Activities	-8,886	-1,054	-3,466	-5,400	-2,040	-1,347	-2,513	-917	-2,397	-6,291
Purchase of Property, Plant & Equipment	-	-	-1,254	-1,324	-1,374	-996	-1,554	-1,523	-1,817	-2,578
Acquisitions	-	-	-2,211	-4,076	-727	-351	-1,494	-3,253	-640	-4,900
Purchase of Investments	-	-	-	-	-	-	0.00	-11	-1.00	-9.00
Sale of Property, Plant & Equipment	-958	-897	-	-	-	-	387	115	104	272
Divestitures	-7,927	-157	-	-	-	-	120	3,712	0.00	1,001
Sale and/or Maturity of Investments	-	-	-	-	39	-	32	36	44	44
Other Investing Activities, net	-	-	-	-	22	-	-4.00	7.00	-87	-121
Net Cash From Financing Activities	3,648	-1,570	470	3,339	2,546	697	-3,107	-2,499	-2,380	-1,186
Net Cash From Continuing Financing Activities	3,648	-1,570	470	3,339	-2,485	697	-3,107	-2,499	-2,378	-1,186
Repayment of Debt	-41	0.00	-434	-291	-996	-4,943	-1,183	-364	-1,462	-1,859
Repurchase of Common Equity	-	-	-3.60	-921	-954	-249	-896	-1,178	-3,067	-1,482
Payment of Dividends	-416	-379	-573	-633	-663	-722	-946	-943	-975	-1,740
Issuance of Debt	4,105	-1,191	1,480	5,184	106	6,611	0.00	38	3,163	4,001
Other Financing Activities, net	-	-	-	-	22	-	-82	-52	-37	-106
Effect of Exchange Rate Changes	-	-	-	-	-	-	-297	-231	208	-143
Cash Interest Paid	328	364	381	394	-	432	340	329	418	599
Cash Income Taxes Paid	-	-	-	-	-	-	642	1,043	959	960

This table details how cash moves in and out of CRH's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Change in Cash & Equivalents	-1,286	-375	1,447	668	-3,081	637	-866	679
Net Cash From Operating Activities	-671	1,634	1,631	2,423	-712	1,485	1,486	2,730
Net Cash From Continuing Operating Activities	-671	1,634	1,631	2,423	-712	1,485	1,486	2,730
Net Income / (Loss) Continuing Operations	-31	1,212	1,318	573	114	1,309	1,389	709
Consolidated Net Income / (Loss)	-31	1,212	1,318	573	114	1,309	1,389	709
Depreciation Expense	384	401	402	446	397	424	467	510
Non-Cash Adjustments To Reconcile Net Income	36	44	16	451	-105	-80	-155	326
Changes in Operating Assets and Liabilities, net	-1,060	-23	-105	953	-1,118	-168	-215	1,185
Net Cash From Investing Activities	-492	-478	-759	-662	-2,096	-521	-1,788	-1,886
Net Cash From Continuing Investing Activities	-492	-478	-759	-668	-2,096	-521	-1,788	-1,886
Purchase of Property, Plant & Equipment	-332	-439	-404	-642	-506	-624	-505	-943
Acquisitions	-155	-43	-363	-79	-2,206	-316	-1,331	-1,047
Purchase of Investments	-2.00	9.00	-4.00	-4.00	-13	10	-18	12
Sale of Property, Plant & Equipment	6.00	36	22	40	739	357	84	-908
Divestitures	-	-	5.00	-5.00	-	-	27	919
Sale and/or Maturity of Investments	8.00	4.00	11	21	6.00	9.00	7.00	22
Other Investing Activities, net	-17	-45	-26	1.00	-116	-12	-52	59
Net Cash From Financing Activities	-191	-1,555	649	-1,283	-176	-339	-629	-42
Net Cash From Continuing Financing Activities	-191	-1,555	649	-1,281	-176	-339	-629	-42
Repayment of Debt	0.00	-849	-91	-522	-651	-1,040	-163	-5.00
Repurchase of Common Equity	-246	-713	-1,072	-1,036	-559	-348	-317	-258
Payment of Dividends	-13	-771	-12	-179	-767	-486	-249	-238
Issuance of Debt	71	784	1,832	476	1,818	1,552	82	549
Other Financing Activities, net	-3.00	-6.00	-8.00	-20	-17	-17	18	-90
Effect of Exchange Rate Changes	68	24	-74	190	-97	12	65	-123
Cash Interest Paid	54	147	43	174	45	171	156	227
Cash Income Taxes Paid	104	173	343	339	159	145	350	306

This table presents CRH's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Total Assets	33,237	37,999	46,777	47,612	44,944	44,670	45,319	47,469	50,613
Total Current Assets	9,882	11,737	17,395	17,258	14,977	14,044	14,833	16,885	14,083
Cash & Equivalents	2,576	2,541	9,191	9,918	7,721	5,783	5,936	6,341	3,720
Restricted Cash	-	-	-	-	-	-	-	0.00	39
Accounts Receivable	4,186	4,361	4,665	4,231	4,086	4,569	4,300	4,507	4,820
Inventories, net	3,092	3,261	3,505	3,080	3,117	3,611	4,194	4,291	4,755
Other Current Assets	-	-	-	-	-	-	403	478	749
Other Current Nonoperating Assets	-	-	-	-	-	-	-	1,268	0.00
Plant, Property, & Equipment, net	13,350	15,729	18,046	19,574	19,317	19,502	17,768	17,841	21,452
Total Noncurrent Assets	10,005	10,533	11,336	10,780	10,650	11,124	12,718	12,743	15,078
Long-Term Investments	1,367	1,499	1,332	775	626	653	649	620	737
Goodwill	-	-	-	-	-	-	9,199	9,158	11,061
Intangible Assets	8,165	8,666	9,656	9,475	9,373	9,848	1,088	1,041	1,211
Other Noncurrent Operating Assets	83	66	60	98	197	275	1,782	1,924	2,069
Total Liabilities & Shareholders' Equity	33,237	37,999	46,777	47,612	44,944	44,670	45,319	47,469	50,613
Total Liabilities	18,043	20,008	27,825	27,977	24,596	23,756	22,279	25,848	27,763
Total Current Liabilities	6,690	7,516	14,006	13,411	7,465	7,581	8,041	10,013	10,296
Short-Term Debt	289	380	7,213	6,616	1,257	549	1,491	1,866	2,999
Accounts Payable	5,550	5,718	5,817	5,461	5,503	6,409	2,930	3,149	3,207
Accrued Expenses	-	-	-	-	-	-	2,132	2,296	2,248
Other Current Liabilities	436	869	468	769	797	790	1,488	2,327	1,842
Other Current Nonoperating Liabilities	-	-	-	-	-	-	0.00	375	0.00
Total Noncurrent Liabilities	11,353	12,492	13,819	14,566	17,131	16,175	14,238	15,835	17,467
Long-Term Debt	7,906	9,202	9,959	9,211	10,958	9,938	8,145	9,776	10,969
Noncurrent Deferred & Payable Income Tax Liabilities	2,112	2,001	2,530	2,627	2,613	2,734	2,885	2,738	3,105
Other Noncurrent Operating Liabilities	713	836	844	855	954	937	3,208	3,321	3,393
Commitments & Contingencies	-	-	-	-	-	-	0.00	0.00	0.00
Redeemable Noncontrolling Interest	-	-	-	-	-	-	308	333	384
Total Equity & Noncontrolling Interests	15,193	17,990	18,951	19,634	20,347	20,914	22,732	21,288	22,466
Total Preferred & Common Equity	14,616	17,406	18,349	19,027	40,004	20,233	22,157	20,854	21,607
Preferred Stock	-	-	-	-	7,493	-	1.00	1.00	1.00
Total Common Equity	14,616	17,406	18,349	19,027	12,162	20,232	22,156	20,853	21,606
Common Stock	299	344	352	335	333	309	745	750	712
Retained Earnings	6,809	9,493	11,705	11,350	11,565	19,770	22,495	22,918	24,036
Treasury Stock	-15	-18	-920	-360	-386	-195	-297	-2,199	-2,137
Accumulated Other Comprehensive Income / (Loss)	-	-	-	-	-	-	-787	-616	-1,005
Noncontrolling Interest	576	584	602	607	692	681	575	434	859

This table presents CRH's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Period end date	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024
Total Assets	45,107	46,142	47,631	46,333	48,105	51,221
Total Current Assets	14,230	15,074	16,315	13,709	15,113	14,840
Cash & Equivalents	4,650	4,275	5,722	3,308	3,066	2,978
Restricted Cash	-	0.00	0.00	-	869	102
Accounts Receivable	4,706	6,119	5,972	4,798	5,893	6,422
Inventories, net	4,458	4,276	4,191	4,619	4,514	4,644
Other Current Assets	416	404	430	748	704	694
Other Current Nonoperating Assets	0.00	0.00	0.00	236	67	0.00
Plant, Property, & Equipment, net	17,997	18,155	18,103	18,878	19,235	21,289
Total Noncurrent Assets	12,880	12,913	13,213	13,746	13,757	15,092
Long-Term Investments	655	672	665	609	484	929
Goodwill	9,308	9,338	9,545	10,125	10,251	10,906
Intangible Assets	1,094	1,061	1,074	1,093	1,086	1,105
Other Noncurrent Operating Assets	1,823	1,842	1,929	1,919	1,936	2,152
Total Liabilities & Shareholders' Equity	45,107	46,142	47,631	46,333	48,105	51,221
Total Liabilities	22,963	23,433	24,983	25,591	26,654	28,055
Total Current Liabilities	9,255	9,671	9,191	9,997	10,548	10,668
Short-Term Debt	2,251	2,185	1,860	2,992	3,218	3,218
Accounts Payable	2,627	3,553	2,954	2,730	3,363	2,963
Accrued Expenses	2,079	2,335	2,457	2,241	2,272	2,513
Other Current Liabilities	2,298	1,598	1,920	1,990	1,681	1,974
Other Current Nonoperating Liabilities	0.00	0.00	0.00	44	14	0.00
Total Noncurrent Liabilities	13,708	13,762	15,792	15,594	16,106	17,387
Long-Term Debt	7,583	7,563	9,535	9,680	9,900	10,672
Noncurrent Deferred & Payable Income Tax Liabilities	2,972	3,010	3,050	2,684	2,914	3,168
Other Noncurrent Operating Liabilities	3,153	3,189	3,207	3,230	3,292	3,547
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	307	313	320	326	335	361
Total Equity & Noncontrolling Interests	21,837	22,396	22,328	20,416	21,116	22,805
Total Preferred & Common Equity	21,255	21,821	21,767	20,015	20,726	21,875
Preferred Stock	1.00	1.00	1.00	1.00	1.00	1.00
Total Common Equity	21,254	21,820	21,766	20,014	20,725	21,874
Common Stock	722	693	725	631	651	683
Retained Earnings	21,692	22,892	23,936	22,346	23,030	23,831
Treasury Stock	-487	-1,140	-2,132	-2,166	-2,143	-2,141
Accumulated Other Comprehensive Income / (Loss)	-673	-625	-763	-797	-813	-499
Noncontrolling Interest	582	575	561	401	390	930

This table displays calculated financial ratios and metrics derived from CRH's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	12.12%	-0.26%	5.43%	0.00%	0.00%	12.82%	12.04%	6.80%	1.78%
EBITDA Growth	0.00%	39.55%	12.91%	-9.14%	-45.15%	95.80%	41.98%	7.03%	9.40%	20.01%
EBIT Growth	0.00%	56.03%	12.43%	-16.16%	-100.00%	0.00%	82.24%	9.45%	11.87%	23.88%
NOPAT Growth	0.00%	66.12%	56.01%	-18.51%	-100.00%	0.00%	87.05%	12.95%	8.45%	17.70%
Net Income Growth	0.00%	68.67%	72.54%	25.33%	-39.84%	-32.97%	130.56%	44.79%	-21.01%	14.62%
EPS Growth	0.00%	68.09%	81.60%	0.00%	0.00%	0.00%	133.80%	53.92%	-15.26%	15.94%
Operating Cash Flow Growth	0.00%	-242.79%	-58.43%	-62.44%	199.90%	6.06%	-3.33%	-4.50%	32.03%	-0.56%
Free Cash Flow Firm Growth	0.00%	0.00%	97.57%	-257.21%	63.29%	454.28%	-7.67%	70.22%	22.77%	-179.97%
Invested Capital Growth	0.00%	0.00%	14.08%	15.47%	2.23%	-2.36%	2.98%	-0.79%	-2.61%	27.21%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.52%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	6.11%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	6.98%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	8.69%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	4.02%
EPS Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	1.01%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	6.56%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-2.19%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	31.13%	33.17%	34.07%	33.03%	0.00%	33.08%	33.65%	33.05%	34.23%	35.71%
EBITDA Margin	9.59%	11.94%	13.51%	11.88%	0.00%	13.52%	17.01%	16.25%	16.64%	19.63%
Operating Margin	5.45%	7.70%	8.90%	8.92%	0.00%	7.83%	11.39%	11.64%	11.98%	13.85%
EBIT Margin	5.65%	7.87%	8.87%	7.27%	0.00%	7.24%	11.70%	11.43%	11.97%	14.57%
Profit (Net Income) Margin	3.41%	5.12%	8.86%	10.53%	0.00%	4.50%	9.20%	11.88%	8.79%	9.90%
Tax Burden Percent	79.24%	78.40%	113.89%	144.96%	0.00%	80.12%	86.59%	112.37%	76.53%	74.69%
Interest Burden Percent	76.03%	83.08%	87.76%	100.00%	0.00%	77.55%	90.78%	92.54%	95.94%	90.95%
Effective Tax Rate	30.00%	26.60%	0.71%	23.43%	0.00%	30.61%	20.95%	22.02%	23.04%	23.02%
Return on Invested Capital (ROIC)	0.00%	15.17%	11.06%	7.85%	0.00%	5.44%	10.15%	11.34%	12.51%	13.13%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	8.68%	11.22%	26.67%	0.00%	1.33%	11.21%	33.12%	8.14%	9.06%
Return on Net Nonoperating Assets (RNNOA)	0.00%	2.42%	2.84%	7.80%	0.00%	0.39%	2.87%	6.36%	1.25%	2.70%
Return on Equity (ROE)	0.00%	17.59%	13.89%	15.64%	9.01%	5.83%	13.02%	17.70%	13.76%	15.84%
Cash Return on Invested Capital (CROIC)	0.00%	-184.83%	-2.09%	-6.52%	-2.21%	7.83%	7.21%	12.14%	15.16%	-10.81%
Operating Return on Assets (OROA)	0.00%	6.17%	6.48%	4.70%	0.00%	4.05%	7.63%	8.31%	9.02%	10.57%
Return on Assets (ROA)	0.00%	4.02%	6.47%	6.82%	0.00%	2.52%	5.99%	8.64%	6.62%	7.18%
Return on Common Equity (ROCE)	0.00%	16.92%	13.41%	15.14%	8.73%	4.55%	10.22%	17.07%	13.25%	15.12%
Return on Equity Simple (ROE_SIMPLE)	0.00%	9.14%	13.24%	15.74%	9.13%	2.91%	13.28%	17.55%	14.73%	16.30%
Net Operating Profit after Tax (NOPAT)	887	1,473	2,298	1,873	0.00	1,406	2,630	2,970	3,221	3,791
NOPAT Margin	3.81%	5.65%	8.84%	6.83%	0.00%	5.43%	9.00%	9.08%	9.22%	10.66%
Net Nonoperating Expense Percent (NNEP)	0.00%	6.49%	-0.16%	-18.82%	-26.43%	4.11%	-1.06%	-21.78%	4.37%	4.08%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	9.18%	9.78%	10.41%
Cost of Revenue to Revenue	68.87%	66.83%	65.93%	67.06%	0.00%	66.92%	66.35%	66.95%	65.77%	64.30%
SG&A Expenses to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	22.39%	21.56%	21.42%	22.07%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	25.68%	25.48%	25.17%	24.11%	0.00%	25.26%	22.26%	21.41%	22.25%	21.86%
Earnings before Interest and Taxes (EBIT)	1,315	2,051	2,306	1,993	0.00	1,875	3,417	3,740	4,184	5,183
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	2,231	3,113	3,515	3,258	1,787	3,499	4,968	5,317	5,817	6,981
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	1.09	1.65	2.68	2.03	1.30	2.46	2.91
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	2.29	3.29	11.67	3.96	2.43	4.81	6.73
Price to Revenue (P/Rev)	0.00	0.00	0.00	0.73	0.00	1.26	1.41	0.88	1.46	1.77
Price to Earnings (P/E)	0.00	0.00	0.00	6.90	0.00	24.95	15.65	7.46	16.11	18.00
Dividend Yield	2.84%	2.38%	2.27%	3.41%	2.15%	2.23%	2.26%	0.00%	1.95%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	14.48%	0.00%	4.01%	6.39%	13.41%	6.21%	5.56%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	1.06	1.48	1.80	1.80	1.25	2.23	2.28
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	0.00	0.99	0.00	1.77	1.62	1.00	1.62	2.07
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	8.34	21.60	13.12	9.51	6.16	9.74	10.54
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	13.64	0.00	24.49	13.82	8.75	13.54	14.19
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	14.51	0.00	32.65	17.96	11.02	17.58	19.40
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	9.95	11.15	11.87	8.62	11.29	14.75
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	22.69	25.28	10.30	14.51	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.54	0.53	0.91	0.88	0.67	0.57	0.42	0.54	0.61
Long-Term Debt to Equity	0.00	0.52	0.51	0.53	0.54	0.60	0.54	0.35	0.45	0.48
Financial Leverage	0.00	0.28	0.25	0.29	0.34	0.29	0.26	0.19	0.15	0.30
Leverage Ratio	0.00	2.19	2.15	2.29	2.45	2.32	2.17	2.05	2.08	2.21
Compound Leverage Factor	0.00	1.82	1.88	2.29	0.00	1.80	1.97	1.89	1.99	2.01
Debt to Total Capital	0.00%	35.04%	34.75%	47.54%	46.72%	39.98%	36.19%	29.49%	35.00%	37.94%
Short-Term Debt to Total Capital	0.00%	1.24%	1.38%	19.97%	17.95%	3.71%	1.68%	4.56%	5.61%	8.15%
Long-Term Debt to Total Capital	0.00%	33.80%	33.37%	27.57%	28.77%	36.27%	34.51%	24.93%	29.39%	29.79%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	22.10%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	2.46%	2.12%	1.67%	1.65%	2.04%	2.08%	2.70%	2.31%	3.38%
Common Equity to Total Capital	0.00%	62.50%	63.13%	50.80%	51.63%	35.88%	61.73%	67.81%	62.69%	58.68%
Debt to EBITDA	0.00	2.63	2.73	5.27	9.64	3.87	2.39	1.81	2.00	2.00
Net Debt to EBITDA	0.00	1.36	1.56	2.04	3.65	1.48	1.08	0.57	0.80	1.36
Long-Term Debt to EBITDA	0.00	2.54	2.62	3.06	5.93	3.51	2.28	1.53	1.68	1.57
Debt to NOPAT	0.00	5.56	4.17	9.17	0.00	9.64	4.51	3.24	3.61	3.68
Net Debt to NOPAT	0.00	2.87	2.39	3.54	0.00	3.69	2.05	1.03	1.45	2.50
Long-Term Debt to NOPAT	0.00	5.37	4.00	5.32	0.00	8.75	4.30	2.74	3.03	2.89
Altman Z-Score	0.00	0.00	0.00	1.59	1.11	2.07	2.74	2.64	3.07	3.15
Noncontrolling Interest Sharing Ratio	0.00%	3.79%	3.50%	3.21%	3.13%	21.99%	21.49%	3.56%	3.70%	4.52%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.00	1.48	1.56	1.24	1.29	2.01	1.85	1.84	1.69	1.37
Quick Ratio	0.00	1.01	0.92	0.99	1.06	1.58	1.37	1.27	1.08	0.83
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-17,949	-435	-1,555	-571	2,023	1,868	3,179	3,903	-3,122
Operating Cash Flow to CapEx	110.32%	-168.23%	-190.71%	-293.43%	282.46%	413.25%	340.96%	269.89%	292.88%	216.35%
Free Cash Flow to Firm to Interest Expense	0.00	-43.64	-1.20	0.00	0.00	4.62	5.93	9.24	10.38	-5.10
Operating Cash Flow to Interest Expense	2.45	-3.67	-6.61	0.00	0.00	9.40	12.63	11.05	13.34	8.15
Operating Cash Flow Less CapEx to Interest Expense	0.23	-5.85	-10.08	0.00	0.00	7.12	8.93	6.95	8.79	4.38
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.00	0.78	0.73	0.65	0.00	0.56	0.65	0.73	0.75	0.73
Accounts Receivable Turnover	0.00	6.23	6.09	6.08	0.00	6.23	6.75	7.38	7.94	7.63
Inventory Turnover	0.00	5.64	5.40	5.44	0.00	5.59	5.76	5.61	5.42	5.06
Fixed Asset Turnover	0.00	1.95	1.79	1.62	0.00	1.33	1.50	1.76	1.96	1.81
Accounts Payable Turnover	0.00	3.14	3.04	3.19	0.00	3.16	3.25	4.69	7.56	7.20
Days Sales Outstanding (DSO)	0.00	58.59	59.97	60.06	0.00	58.63	54.08	49.46	45.99	47.85
Days Inventory Outstanding (DIO)	0.00	64.76	67.62	67.15	0.00	65.29	63.36	65.02	67.37	72.18
Days Payable Outstanding (DPO)	0.00	116.25	119.93	114.46	0.00	115.51	112.18	77.80	48.26	50.72
Cash Conversion Cycle (CCC)	0.00	7.10	7.66	12.74	0.00	8.41	5.26	36.68	65.09	69.32
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	0.00	19,422	22,156	25,584	26,155	25,538	26,300	26,091	25,409	32,322
Invested Capital Turnover	0.00	2.69	1.25	1.15	0.00	1.00	1.13	1.25	1.36	1.23
Increase / (Decrease) in Invested Capital	0.00	19,422	2,734	3,428	571	-617	762	-209	-682	6,913
Enterprise Value (EV)	0.00	0.00	0.00	27,179	38,598	45,909	47,228	32,740	56,643	73,568
Market Capitalization	0.00	0.00	0.00	19,945	31,471	32,534	41,161	28,805	51,194	62,852
Book Value per Share	$0.00	$0.00	$20.75	$21.87	$22.56	$15.21	$25.44	$29.22	$27.72	$31.80
Tangible Book Value per Share	$0.00	$0.00	$10.42	$10.36	$11.33	$3.49	$13.06	$15.65	$14.16	$13.74
Total Capital	0.00	23,388	27,571	36,123	36,854	33,901	32,775	32,676	33,263	36,818
Total Debt	0.00	8,195	9,581	17,172	17,220	13,554	11,861	9,636	11,642	13,968
Total Long-Term Debt	0.00	7,906	9,202	9,959	10,604	12,297	11,312	8,145	9,776	10,969
Net Debt	0.00	4,228	5,501	6,632	6,520	5,190	5,386	3,051	4,681	9,472
Capital Expenditures (CapEx)	958	897	1,254	1,324	1,374	996	1,167	1,408	1,713	2,306
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	882	2,019	1,394	538	1,031	1,190	2,347	2,397	3,027
Debt-free Net Working Capital (DFNWC)	0.00	3,482	4,601	10,602	10,463	8,769	7,012	8,283	8,738	6,786
Net Working Capital (NWC)	0.00	3,193	4,221	3,389	3,847	7,512	6,463	6,792	6,872	3,787
Net Nonoperating Expense (NNE)	95	137	-6.88	-1,016	-1,738	241	-56	-919	149	270
Net Nonoperating Obligations (NNO)	0.00	4,229	4,166	6,633	6,521	5,191	5,386	3,051	3,788	9,472
Total Depreciation and Amortization (D&A)	916	1,061	1,208	1,265	1,787	1,624	1,551	1,577	1,633	1,798
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	3.38%	7.76%	5.08%	0.00%	3.98%	4.07%	7.17%	6.86%	8.51%
Debt-free Net Working Capital to Revenue	0.00%	13.35%	17.69%	38.66%	0.00%	33.87%	24.01%	25.31%	25.00%	19.08%
Net Working Capital to Revenue	0.00%	12.24%	16.23%	12.36%	0.00%	29.02%	22.13%	20.76%	19.66%	10.65%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$2.27	$3.02	$2.41	$142.90	$0.00	$5.07	$4.36	$5.06
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	838.96M	843.39M	799.64M	795.14M	0.00	752.14M	723.90M	683.30M
Adjusted Diluted Earnings per Share	$0.00	$0.00	$2.25	$3.01	$2.39	$141.80	$0.00	$5.03	$4.33	$5.02
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	838.96M	843.39M	799.64M	795.14M	0.00	752.14M	729.20M	689.50M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	838.96M	843.39M	799.64M	795.14M	0.00	752.14M	690.36M	676.48M
Normalized Net Operating Profit after Tax (NOPAT)	887	1,473	2,298	1,873	0.00	1,406	2,600	2,931	3,445	3,733
Normalized NOPAT Margin	3.81%	5.65%	8.84%	6.83%	0.00%	5.43%	8.90%	8.96%	9.86%	10.49%
Pre Tax Income Margin	4.30%	6.54%	7.78%	7.27%	0.00%	5.62%	10.62%	10.58%	11.49%	13.25%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	3.05	4.99	6.38	0.00	0.00	4.28	10.85	10.87	11.13	8.47
NOPAT to Interest Expense	2.06	3.58	6.36	0.00	0.00	3.21	8.35	8.63	8.57	6.20
EBIT Less CapEx to Interest Expense	0.83	2.81	2.91	0.00	0.00	2.01	7.14	6.78	6.57	4.70
NOPAT Less CapEx to Interest Expense	-0.17	1.40	2.89	0.00	0.00	0.94	4.64	4.54	4.01	2.43
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	52.54%	28.35%	24.86%	21.91%	38.15%	61.97%	35.22%	24.25%	31.74%	49.42%
Augmented Payout Ratio	52.54%	28.35%	25.01%	53.79%	93.04%	83.35%	68.58%	54.54%	131.58%	91.51%

This table displays calculated financial ratios and metrics derived from CRH's official financial filings.

Metric	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	0.00%	0.00%	0.00%	1.65%	-0.57%	3.82%	2.13%
EBITDA Growth	0.00%	0.00%	0.00%	0.00%	51.81%	12.90%	13.78%	32.84%
EBIT Growth	0.00%	0.00%	0.00%	0.00%	9,350.00%	14.67%	13.25%	43.44%
NOPAT Growth	0.00%	0.00%	0.00%	0.00%	2,283.84%	12.21%	4.29%	48.98%
Net Income Growth	0.00%	0.00%	0.00%	0.00%	467.74%	8.00%	5.39%	23.73%
EPS Growth	0.00%	0.00%	0.00%	0.00%	420.00%	16.05%	9.44%	5.21%
Operating Cash Flow Growth	0.00%	0.00%	0.00%	0.00%	-6.11%	-9.12%	-8.89%	12.67%
Free Cash Flow Firm Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Invested Capital Growth	0.00%	0.00%	0.00%	0.00%	9.87%	9.40%	19.49%	27.21%
Revenue Q/Q Growth	0.00%	51.07%	4.32%	-14.25%	0.00%	47.77%	8.92%	-15.64%
EBITDA Q/Q Growth	0.00%	422.28%	8.68%	-44.14%	0.00%	288.40%	9.53%	-34.78%
EBIT Q/Q Growth	0.00%	80,650.00%	10.77%	-56.51%	0.00%	879.89%	9.40%	-44.92%
NOPAT Q/Q Growth	0.00%	87,442.41%	10.60%	-53.25%	0.00%	4,020.55%	2.80%	-33.22%
Net Income Q/Q Growth	0.00%	4,009.68%	8.75%	-56.53%	0.00%	1,048.25%	6.11%	-48.96%
EPS Q/Q Growth	0.00%	3,340.00%	11.11%	-46.67%	0.00%	1,075.00%	4.79%	-48.73%
Operating Cash Flow Q/Q Growth	0.00%	343.52%	-0.18%	48.56%	0.00%	308.57%	0.07%	83.71%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	53.37%	-228.21%	-50.07%
Invested Capital Q/Q Growth	0.00%	3.14%	0.53%	-8.12%	0.00%	2.70%	9.80%	-2.19%
Profitability Metrics	-	-	-	-	-	-	-	-
Gross Margin	25.19%	37.39%	37.15%	33.98%	27.66%	38.07%	38.60%	35.63%
EBITDA Margin	6.01%	20.76%	21.63%	14.09%	8.97%	23.58%	23.71%	18.33%
Operating Margin	0.03%	16.61%	17.65%	9.02%	0.43%	18.95%	18.68%	12.45%
EBIT Margin	0.03%	16.63%	17.66%	8.96%	2.89%	19.18%	19.27%	12.58%
Profit (Net Income) Margin	-0.48%	12.48%	13.01%	6.60%	1.75%	13.56%	13.21%	7.99%
Tax Burden Percent	79.49%	76.81%	76.63%	75.89%	115.15%	75.53%	73.30%	71.83%
Interest Burden Percent	-1,950.00%	97.71%	96.14%	97.04%	52.38%	93.57%	93.53%	88.44%
Effective Tax Rate	0.00%	24.02%	24.19%	19.07%	-19.19%	24.81%	28.02%	14.49%
Return on Invested Capital (ROIC)	0.00%	0.00%	0.00%	10.04%	0.64%	17.31%	15.67%	13.12%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	0.00%	8.43%	1.87%	16.32%	15.34%	9.57%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	0.00%	1.48%	0.57%	4.97%	4.99%	2.85%
Return on Equity (ROE)	0.00%	0.00%	0.00%	11.51%	1.21%	22.28%	20.66%	15.97%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	0.00%	15.36%	0.00%	0.00%	0.00%	-10.81%
Operating Return on Assets (OROA)	0.00%	0.00%	0.00%	6.75%	2.22%	14.25%	13.79%	9.13%
Return on Assets (ROA)	0.00%	0.00%	0.00%	4.97%	1.34%	10.07%	9.46%	5.80%
Return on Common Equity (ROCE)	0.00%	0.00%	0.00%	11.09%	1.17%	21.47%	19.68%	15.25%
Return on Equity Simple (ROE_SIMPLE)	0.00%	0.00%	0.00%	0.00%	16.07%	15.99%	15.47%	0.00%
Net Operating Profit after Tax (NOPAT)	1.40	1,226	1,356	634	33	1,375	1,414	944
NOPAT Margin	0.02%	12.62%	13.38%	7.30%	0.51%	14.24%	13.44%	10.64%
Net Nonoperating Expense Percent (NNEP)	0.72%	0.28%	0.75%	1.60%	-1.23%	0.98%	0.33%	3.55%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	1.92%	-	-	-	2.59%
Cost of Revenue to Revenue	74.81%	62.61%	62.85%	66.02%	72.34%	61.93%	61.40%	64.37%
SG&A Expenses to Revenue	25.24%	20.96%	19.65%	21.17%	27.35%	20.18%	20.77%	21.79%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	25.16%	20.77%	19.50%	24.96%	27.23%	19.12%	19.92%	23.18%
Earnings before Interest and Taxes (EBIT)	2.00	1,615	1,789	778	189	1,852	2,026	1,116
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	386	2,016	2,191	1,224	586	2,276	2,493	1,626
Valuation Ratios	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.70	1.83	1.83	2.46	2.98	2.48	2.89	2.91
Price to Tangible Book Value (P/TBV)	3.33	3.49	3.57	4.81	6.77	5.48	6.42	6.73
Price to Revenue (P/Rev)	0.00	0.00	0.00	1.46	1.70	1.47	1.79	1.77
Price to Earnings (P/E)	0.00	0.00	0.00	16.11	17.93	15.05	18.14	18.00
Dividend Yield	0.00%	0.00%	0.00%	1.95%	1.95%	2.71%	2.56%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	6.21%	5.58%	6.64%	5.51%	5.56%
Enterprise Value to Invested Capital (EV/IC)	1.56	1.66	1.65	2.23	2.36	2.02	2.25	2.28
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	0.00	1.62	1.97	1.74	2.11	2.07
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	9.74	11.47	9.70	11.32	10.54
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	13.54	15.79	13.22	15.38	14.19
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	17.58	21.06	17.76	21.35	19.40
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	11.29	13.87	12.62	15.91	14.75
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-
Debt to Equity	0.44	0.43	0.50	0.54	0.61	0.61	0.60	0.61
Long-Term Debt to Equity	0.34	0.33	0.42	0.45	0.47	0.46	0.46	0.48
Financial Leverage	0.20	0.21	0.22	0.18	0.31	0.30	0.33	0.30
Leverage Ratio	2.04	2.03	2.10	2.08	2.13	2.13	2.16	2.21
Compound Leverage Factor	-39.72	1.99	2.02	2.02	1.12	2.00	2.02	1.95
Debt to Total Capital	30.75%	30.03%	33.47%	35.00%	37.92%	37.95%	37.48%	37.94%
Short-Term Debt to Total Capital	7.04%	6.73%	5.46%	5.61%	8.95%	9.31%	8.68%	8.15%
Long-Term Debt to Total Capital	23.71%	23.30%	28.01%	29.39%	28.97%	28.64%	28.80%	29.79%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	2.78%	2.74%	2.59%	2.31%	2.18%	2.10%	3.48%	3.38%
Common Equity to Total Capital	66.46%	67.23%	63.94%	62.69%	59.90%	59.95%	59.03%	58.68%
Debt to EBITDA	0.00	0.00	0.00	2.00	2.11	2.09	2.11	2.00
Net Debt to EBITDA	0.00	0.00	0.00	0.80	1.46	1.39	1.50	1.36
Long-Term Debt to EBITDA	0.00	0.00	0.00	1.68	1.61	1.58	1.62	1.57
Debt to NOPAT	0.00	0.00	0.00	3.61	3.86	3.82	3.98	3.68
Net Debt to NOPAT	0.00	0.00	0.00	1.45	2.67	2.54	2.83	2.50
Long-Term Debt to NOPAT	0.00	0.00	0.00	3.03	2.95	2.89	3.06	2.89
Altman Z-Score	0.00	0.00	0.00	2.83	2.94	2.80	2.92	2.89
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	3.70%	3.77%	3.66%	4.75%	4.52%
Liquidity Ratios	-	-	-	-	-	-	-	-
Current Ratio	1.54	1.56	1.78	1.69	1.37	1.43	1.39	1.37
Quick Ratio	1.01	1.07	1.27	1.08	0.81	0.85	0.88	0.83
Cash Flow Metrics	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	0.00	0.00	0.00	-2,599	-1,212	-3,977	-5,969
Operating Cash Flow to CapEx	-205.83%	405.46%	426.96%	402.49%	0.00%	556.18%	352.97%	147.49%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	-19.54	-7.82	-24.25	-37.31
Operating Cash Flow to Interest Expense	-8.28	22.38	12.45	26.63	-5.35	9.58	9.06	17.06
Operating Cash Flow Less CapEx to Interest Expense	-12.31	16.86	9.53	20.01	-3.60	7.86	6.49	5.49
Efficiency Ratios	-	-	-	-	-	-	-	-
Asset Turnover	0.00	0.00	0.00	0.75	0.77	0.74	0.72	0.73
Accounts Receivable Turnover	0.00	0.00	0.00	7.94	7.38	5.83	5.71	7.63
Inventory Turnover	0.00	0.00	0.00	5.42	5.05	5.19	5.18	5.06
Fixed Asset Turnover	0.00	0.00	0.00	1.96	1.90	1.87	1.80	1.81
Accounts Payable Turnover	0.00	0.00	0.00	7.56	8.55	6.59	7.74	7.20
Days Sales Outstanding (DSO)	0.00	0.00	0.00	45.99	49.48	62.63	63.92	47.85
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	67.37	72.33	70.35	70.43	72.18
Days Payable Outstanding (DPO)	0.00	0.00	0.00	48.26	42.68	55.35	47.17	50.72
Cash Conversion Cycle (CCC)	0.00	0.00	0.00	65.09	79.12	77.63	87.18	69.32
Capital & Investment Metrics	-	-	-	-	-	-	-	-
Invested Capital	26,673	27,510	27,656	25,409	29,305	30,097	33,047	32,322
Invested Capital Turnover	0.00	0.00	0.00	1.38	1.25	1.22	1.17	1.23
Increase / (Decrease) in Invested Capital	0.00	0.00	0.00	0.00	2,632	2,587	5,391	6,913
Enterprise Value (EV)	41,537	45,573	45,711	56,643	69,033	60,912	74,494	73,568
Market Capitalization	36,118	39,883	39,821	51,194	59,550	51,487	63,321	62,852
Book Value per Share	$28.26	$29.01	$28.94	$27.72	$29.10	$30.18	$32.04	$31.80
Tangible Book Value per Share	$14.43	$15.18	$14.82	$14.16	$12.79	$13.67	$14.45	$13.74
Total Capital	31,978	32,457	34,043	33,263	33,414	34,569	37,056	36,818
Total Debt	9,834	9,748	11,395	11,642	12,672	13,118	13,890	13,968
Total Long-Term Debt	7,583	7,563	9,535	9,776	9,680	9,900	10,672	10,969
Net Debt	4,529	4,801	5,008	4,681	8,755	8,699	9,881	9,472
Capital Expenditures (CapEx)	326	403	382	602	-233	267	421	1,851
Debt-free, Cash-free Net Working Capital (DFCFNWC)	2,576	3,313	3,262	2,397	3,396	3,848	4,310	3,027
Debt-free Net Working Capital (DFNWC)	7,226	7,588	8,984	8,738	6,704	7,783	7,390	6,786
Net Working Capital (NWC)	4,975	5,403	7,124	6,872	3,712	4,565	4,172	3,787
Net Nonoperating Expense (NNE)	32	14	38	61	-81	66	25	235
Net Nonoperating Obligations (NNO)	4,529	4,801	5,008	3,788	8,563	8,646	9,881	9,472
Total Depreciation and Amortization (D&A)	384	401	402	446	397	424	467	510
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	0.00%	0.00%	6.86%	9.69%	10.99%	12.18%	8.51%
Debt-free Net Working Capital to Revenue	0.00%	0.00%	0.00%	25.00%	19.12%	22.24%	20.88%	19.08%
Net Working Capital to Revenue	0.00%	0.00%	0.00%	19.66%	10.59%	13.04%	11.79%	10.65%
Earnings Adjustments	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$0.00	$0.97	$0.16	$1.89	$1.99	$1.02
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	0.00	723.90M	687.80M	685.50M	681.60M	683.30M
Adjusted Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.96	$0.16	$1.88	$1.97	$1.01
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	0.00	729.20M	693.40M	688.80M	685.50M	689.50M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	0.00	690.36M	686.68M	682.78M	679.34M	676.48M
Normalized Net Operating Profit after Tax (NOPAT)	-2.10	1,212	1,344	611	14	1,298	1,350	912
Normalized NOPAT Margin	-0.03%	12.48%	13.27%	7.04%	0.21%	13.45%	12.84%	10.28%
Pre Tax Income Margin	-0.61%	16.25%	16.98%	8.69%	1.52%	17.95%	18.02%	11.13%
Debt Service Ratios	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.02	22.12	13.66	8.55	1.42	11.95	12.35	6.98
NOPAT to Interest Expense	0.02	16.79	10.35	6.96	0.25	8.87	8.62	5.90
EBIT Less CapEx to Interest Expense	-4.00	16.60	10.74	1.93	3.17	10.23	9.79	-4.59
NOPAT Less CapEx to Interest Expense	-4.01	11.27	7.43	0.35	2.00	7.15	6.05	-5.67
Payout Ratios	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	31.74%	53.81%	43.63%	49.72%	49.42%
Augmented Payout Ratio	0.00%	0.00%	0.00%	131.58%	158.87%	134.61%	116.48%	91.51%

Frequently Asked Questions About CRH's Financials

When does CRH's financial year end?

According to the most recent income statement we have on file, CRH's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has CRH's net income changed over the last 9 years?

CRH's net income appears to be on an upward trend, with a most recent value of $3.52 billion in 2024, rising from $792.09 million in 2015. The previous period was $3.07 billion in 2023. Find out what analysts predict for CRH in the coming months.

What is CRH's operating income?

CRH's total operating income in 2024 was $4.93 billion, based on the following breakdown:

Total Gross Profit: $12.70 billion
Total Operating Expenses: $7.78 billion

How has CRH revenue changed over the last 9 years?

Over the last 9 years, CRH's total revenue changed from $23.26 billion in 2015 to $35.57 billion in 2024, a change of 52.9%.

How much debt does CRH have?

CRH's total liabilities were at $27.76 billion at the end of 2024, a 7.4% increase from 2023, and a 53.9% increase since 2016.

How much cash does CRH have?

In the past 8 years, CRH's cash and equivalents has ranged from $2.54 billion in 2017 to $9.92 billion in 2019, and is currently $3.72 billion as of their latest financial filing in 2024.

How has CRH's book value per share changed over the last 9 years?

Over the last 9 years, CRH's book value per share changed from 0.00 in 2015 to 31.80 in 2024, a change of 3,180.5%.

Related Companies

This page (NYSE:CRH) was last updated on 5/6/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

CRH (CRH) Financials

Frequently Asked Questions About CRH's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

CRH (CRH) Financials

Annual Income Statements for CRH

Quarterly Income Statements for CRH

Annual Cash Flow Statements for CRH

Quarterly Cash Flow Statements for CRH

Annual Balance Sheets for CRH

Quarterly Balance Sheets for CRH

Annual Metrics and Ratios for CRH

Quarterly Metrics and Ratios for CRH

Frequently Asked Questions About CRH's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools